Tianshui Zhongxing adjusts guarantees, forecasts 2026 commitments

Tianshui Zhongxing Bio-Technology adjusted its 2025 external guarantee quota, reallocating CNY 3,000 to Jiangsu Zhongyou from Xinxiang Xinghe, bringing Jiangsu Zhongyou's total to CNY 11,000. This adjustment, approved by the general manager’s office, aims to meet operating needs within the existing shareholder-approved total for 2025. Additionally, the company provided a CNY 4,000 joint liability guarantee for a working capital loan to Jiangsu Zhongyou from the Bank of Communications, Xuzhou Branch.

Looking ahead, the company forecasts a total new external guarantee quota of CNY 110,000 for 2026 for its subsidiaries, with CNY 41,000 allocated to those with asset-liability ratios above 70% and CNY 69,000 to those below 70%. The total external guarantee amount, including the new forecast, is expected to reach CNY 227,112.55, representing 68.47% of the latest audited net assets from 2024. The board has also proposed revisions to the "Director and Senior Management Remuneration Management System," which will be submitted for shareholder approval.

These financial strategies, approved by the board on December 9, 2025, are designed to support the operational and project development needs of the company's subsidiaries and will be presented at the fourth extraordinary general meeting of shareholders on December 26, 2025. The company confirms all existing and new guarantees are for consolidated entities, with no external guarantees for unrelated parties.